Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension

被引:33
|
作者
Minami, J [1 ]
Kawano, Y
Makino, Y
Matsuoka, H
Takishita, S
机构
[1] Dokkyo Univ, Sch Med, Dept Med, Div Hypertens & Cardiorenal Dis, Mibu, Tochigi 3210293, Japan
[2] Natl Cardiovasc Ctr, Div Nephrol & Hypertens, Osaka 5650873, Japan
关键词
ambulatory blood pressure; autonomic function; calcium antagonist; cilnidipine; cold presser; heart rate variability; heart rate;
D O I
10.1046/j.1365-2125.2000.00299.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of the present study was to evaluate the effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Methods Ten inpatients with mild to moderate essential hypertension (four men and six women; age: 44-64 years) underwent a drug-free period for 7 days and a treatment period with cilnidipine 10 mg orally for another 7 days, in a randomized crossover study. On the sixth day of each period, they underwent autonomic function tests including a mental arithmetic test, a cold presser test and a Valsalva manoeuvre. After these tests, 24 h ambulatory blood pressure, heart rate, and the electrocardiogram R-R intervals were monitored every 30 min. A power spectral analysis of R-R intervals was performed to obtain the low-and high-frequency components. Results Cilnidipine significantly decreased the 24 h blood pressure by 6.5 +/- 1.7 mm Hg systolic (mean+/-s.e.mean; P<0.01) and 5.0+/-1.1 mmHg diastolic (P<0.01), whereas cilnidipine did not change heart rate or any indices of power spectral components. During the cold presser test, the maximum change in systolic blood pressure and percentage changes in both systolic and diastolic blood pressures were significantly lower during the treatment period with cilnidipine than during the drug-free period. The baroreflex sensitivity measured from the overshoot phase of the Valsalva manoeuvre did not differ significantly between the two periods. Conclusions Cilnidipine is effective as a once-daily antihypertensive agent and causes little influence on heart rate and the autonomic nervous system in patients with mild to moderate essential hypertension. Moreover, it is suggested that cilnidipine has an additional clinical benefit in the inhibition of the presser response induced by acute cold stress.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 50 条
  • [1] Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension Treated with a New Calcium Antagonist, Cilnidipine
    Mitsuhiro Tominaga
    Yusuke Ohya
    Akira Tsukashima
    Kazuo Kobayashi
    Yutaka Takata
    Tokushi Koga
    Yoshiaki Yamashita
    Yae Fujishima
    Isao Abe
    Masatoshi Fujishima
    Cardiovascular Drugs and Therapy, 1997, 11 : 43 - 48
  • [2] Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine
    Tominaga, M
    Ohya, Y
    Tsukashima, A
    Kobayashi, K
    Takata, Y
    Koga, T
    Yamashita, Y
    Fujishima, Y
    Abe, I
    Fujishima, M
    CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (01) : 43 - 48
  • [3] Effects of cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension
    Kai, Tatsuya
    Kuzumoto, Yoshimasa
    Hara, Hidenori
    Kusunoki, Susumu
    Kanamasa, Ken
    JOURNAL OF HYPERTENSION, 2006, 24 : 205 - 205
  • [4] Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension
    Kawano, Y
    Makino, Y
    Okuda, N
    Takishita, S
    Omae, T
    BLOOD PRESSURE MONITORING, 2000, 5 (03) : 181 - 185
  • [5] The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: The VAMPHYRE study
    Lefrandt, JD
    Heitmann, J
    Sevre, K
    Castellano, M
    Hausberg, M
    Fallon, M
    Fluckiger, L
    Urbigkeit, A
    Rostrup, M
    Agabiti-Rosei, E
    Rahn, KH
    Murphy, M
    Zannad, F
    de Kam, PJ
    van Roon, AM
    Smit, AJ
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (11) : 1083 - 1089
  • [6] Effect of a new 1,4-dihydropyridine calcium antagonist, cilnidipine, on 24-h blood pressure, heart rate and autonomic nerve activity in hypertensive patients: Comparison with nifedipine retard
    Minami, J
    Ishimitsu, T
    Kawano, Y
    Numabe, A
    Tsukada, K
    Ogawa, Y
    Ono, H
    Matsuoka, H
    JOURNAL OF HYPERTENSION, 1998, 16 : S230 - S230
  • [7] Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
    Das, Arijit
    Kumar, Prakash
    Kumari, Abha
    Chandra, Satish
    Gari, Manju
    Singh, Nidhi
    Dey, Debleena
    CARDIOLOGY RESEARCH, 2016, 7 (05) : 167 - 172
  • [8] Ambulatory pulse pressure and heart rate variability in patients with essential hypertension
    Ijiri, H
    Kohno, I
    Lida, T
    Takusagawa, M
    Umetani, I
    Sawanobori, T
    Osada, M
    Komori, S
    Tamura, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S47 - S47
  • [9] EFFECTS OF L/N-TYPE CALCIUM CHANNEL BLOCKER CILNIDIPINE ON AMBULATORY BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY IN PATIENTS WITH INTRADIALYTIC HYPERTENSION
    Fujimoto, Naoki
    Ito, Takayasu
    Ishikawa, Eiji
    Dohi, Kaoru
    Kiyohara, Michiyo
    Takeuchi, Hideyuki
    Koyabu, Sukenari
    Nishimura, Hiroyuki
    Takeuchi, Toshiaki
    Ito, Masaaki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [10] Blood pressure and autonomic function in essential hypertension: comparative evaluation of 24-hour heart rate variability and blood pressure
    Pivetti, Vanessa
    Lazzeroni, Davide
    Moderato, Luca
    Centorbi, Claudio Stefano
    Bini, Matteo
    Brambilla, Lorenzo
    Magnani, Giulia
    Piepoli, Massimo
    Ardissino, Diego
    Niccoli, Giampaolo
    Coruzzi, Paolo
    Cabassi, Aderville
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)